Oleuropein as a novel anti-diabetic nutraceutical. An overview by Archives of Diabetes & Obesity in Lupine Publishers
Among the cardiometabolic diseases, type 2 diabetes mellitus (T2DM) is
one of the most diffused worldwide. Pharmacological
treatments commonly used present several side effects, and this is
driving people to search natural approaches. Olea europaea
is currently investigated for its anti-diabetic potential. In
particular, oleuropein (OLE), its main bioactive compound, have been
demonstrated to exert interesting activities in management of T2DM,
including hypoglycemic and antioxidant activities. The
purpose of this manuscript is to review the available scientific
evidence evaluating the role of OLE in managing T2DM.
For more Diabetes Obesity Journal open access journalarticles please click here
No comments:
Post a Comment